ConductScience.org, home

Paper3203058

Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.

Loewen GR and 3 others. Br J Clin Pharmacol, 1988. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. Papers, record 3203058. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3203058

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.36
iCite
Revised in PubMed
2019-05-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Loewen GRG R
2Herman RJR J
3Ross SGS G
4Verbeeck RKR K

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiflunisalMajor topic
GlucuronatesMajor topic
SalicylatesMajor topic
SulfatesMajor topic
Adolescent
Adult
Blood Proteins
Chromatography, High Pressure Liquid
Humans
Male
Protein Binding

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16026259Pharmacokinetics of salicylamide elimination in man.J Pharmacol Exp Ther1967https://conductscience.org/library/papers/6026259PubMed
22868855Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate.Drug Metab Dispos1986https://conductscience.org/library/papers/2868855PubMed
3328032Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.Br J Clin Pharmacol1977https://conductscience.org/library/papers/328032PubMed
4427004Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.Br J Clin Pharmacol1979https://conductscience.org/library/papers/427004PubMed
5466931Salicylate clearance, the resultant of protein binding and metabolism.Clin Pharmacol Ther1979https://conductscience.org/library/papers/466931PubMed
66988202Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.Drugs1980https://conductscience.org/library/papers/6988202PubMed
77370051Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.Biochem Pharmacol1980https://conductscience.org/library/papers/7370051PubMed
87452451Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.J Pharm Sci1980https://conductscience.org/library/papers/7452451PubMed
97048351Drug metabolite kinetics.Pharmacol Ther1981https://conductscience.org/library/papers/7048351PubMed
106754315Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion.Drug Metab Rev1982https://conductscience.org/library/papers/6754315PubMed
116851413Diflunisal disposition and hypouricemic response in osteoarthritis.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6851413PubMed
126344042Review of the animal and clinical pharmacology of diflunisal.Pharmacotherapy1983https://conductscience.org/library/papers/6344042PubMed
136663474High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteers.J Pharm Sci1983https://conductscience.org/library/papers/6663474PubMed
146487489The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487489PubMed
156396057Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.Drug Metab Rev1984https://conductscience.org/library/papers/6396057PubMed
163838756Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine.J Chromatogr1985https://conductscience.org/library/papers/3838756PubMed
174057077Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism.J Pharmacol Exp Ther1985https://conductscience.org/library/papers/4057077PubMed
183841206Steady-state disposition of diflunisal: once- versus twice-daily administration.Pharmacotherapy1985https://conductscience.org/library/papers/3841206PubMed
191220Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.Drug Metab Dispos1975https://conductscience.org/library/papers/1220PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
8329288Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8329288PubMed
7768255Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/7768255PubMed
2338115Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2338115PubMed
2328191The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2328191PubMed
2199127Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet1990https://conductscience.org/library/papers/2199127PubMed
1888623Diflunisal and its conjugates in patients with renal failure.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1888623PubMed
1606992Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1606992PubMed
1395362Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.Clin Pharmacokinet1992https://conductscience.org/library/papers/1395362PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3203058

GET https://conductscience.org/api/papers/v1/3203058/authors